1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Phase I 1.2.3 Phase II 1.2.4 Phase III 1.3 Market by Application 1.3.1 Global HIV Vaccines Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Research Institute 1.3.3 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global HIV Vaccines Market Perspective (2016-2027) 2.2 HIV Vaccines Growth Trends by Regions 2.2.1 HIV Vaccines Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 HIV Vaccines Historic Market Share by Regions (2016-2021) 2.2.3 HIV Vaccines Forecasted Market Size by Regions (2022-2027) 2.3 HIV Vaccines Industry Dynamic 2.3.1 HIV Vaccines Market Trends 2.3.2 HIV Vaccines Market Drivers 2.3.3 HIV Vaccines Market Challenges 2.3.4 HIV Vaccines Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top HIV Vaccines Players by Revenue 3.1.1 Global Top HIV Vaccines Players by Revenue (2016-2021) 3.1.2 Global HIV Vaccines Revenue Market Share by Players (2016-2021) 3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by HIV Vaccines Revenue 3.4 Global HIV Vaccines Market Concentration Ratio 3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2020 3.5 HIV Vaccines Key Players Head office and Area Served 3.6 Key Players HIV Vaccines Product Solution and Service 3.7 Date of Enter into HIV Vaccines Market 3.8 Mergers & Acquisitions, Expansion Plans 4 HIV Vaccines Breakdown Data by Type 4.1 Global HIV Vaccines Historic Market Size by Type (2016-2021) 4.2 Global HIV Vaccines Forecasted Market Size by Type (2022-2027) 5 HIV Vaccines Breakdown Data by Application 5.1 Global HIV Vaccines Historic Market Size by Application (2016-2021) 5.2 Global HIV Vaccines Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America HIV Vaccines Market Size (2016-2027) 6.2 North America HIV Vaccines Market Size by Type 6.2.1 North America HIV Vaccines Market Size by Type (2016-2021) 6.2.2 North America HIV Vaccines Market Size by Type (2022-2027) 6.2.3 North America HIV Vaccines Market Size by Type (2016-2027) 6.3 North America HIV Vaccines Market Size by Application 6.3.1 North America HIV Vaccines Market Size by Application (2016-2021) 6.3.2 North America HIV Vaccines Market Size by Application (2022-2027) 6.3.3 North America HIV Vaccines Market Size by Application (2016-2027) 6.4 North America HIV Vaccines Market Size by Country 6.4.1 North America HIV Vaccines Market Size by Country (2016-2021) 6.4.2 North America HIV Vaccines Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe HIV Vaccines Market Size (2016-2027) 7.2 Europe HIV Vaccines Market Size by Type 7.2.1 Europe HIV Vaccines Market Size by Type (2016-2021) 7.2.2 Europe HIV Vaccines Market Size by Type (2022-2027) 7.2.3 Europe HIV Vaccines Market Size by Type (2016-2027) 7.3 Europe HIV Vaccines Market Size by Application 7.3.1 Europe HIV Vaccines Market Size by Application (2016-2021) 7.3.2 Europe HIV Vaccines Market Size by Application (2022-2027) 7.3.3 Europe HIV Vaccines Market Size by Application (2016-2027) 7.4 Europe HIV Vaccines Market Size by Country 7.4.1 Europe HIV Vaccines Market Size by Country (2016-2021) 7.4.2 Europe HIV Vaccines Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific HIV Vaccines Market Size (2016-2027) 8.2 Asia-Pacific HIV Vaccines Market Size by Type 8.2.1 Asia-Pacific HIV Vaccines Market Size by Type (2016-2021) 8.2.2 Asia-Pacific HIV Vaccines Market Size by Type (2022-2027) 8.2.3 Asia-Pacific HIV Vaccines Market Size by Type (2016-2027) 8.3 Asia-Pacific HIV Vaccines Market Size by Application 8.3.1 Asia-Pacific HIV Vaccines Market Size by Application (2016-2021) 8.3.2 Asia-Pacific HIV Vaccines Market Size by Application (2022-2027) 8.3.3 Asia-Pacific HIV Vaccines Market Size by Application (2016-2027) 8.4 Asia-Pacific HIV Vaccines Market Size by Region 8.4.1 Asia-Pacific HIV Vaccines Market Size by Region (2016-2021) 8.4.2 Asia-Pacific HIV Vaccines Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America HIV Vaccines Market Size (2016-2027) 9.2 Latin America HIV Vaccines Market Size by Type 9.2.1 Latin America HIV Vaccines Market Size by Type (2016-2021) 9.2.2 Latin America HIV Vaccines Market Size by Type (2022-2027) 9.2.3 Latin America HIV Vaccines Market Size by Type (2016-2027) 9.3 Latin America HIV Vaccines Market Size by Application 9.3.1 Latin America HIV Vaccines Market Size by Application (2016-2021) 9.3.2 Latin America HIV Vaccines Market Size by Application (2022-2027) 9.3.3 Latin America HIV Vaccines Market Size by Application (2016-2027) 9.4 Latin America HIV Vaccines Market Size by Country 9.4.1 Latin America HIV Vaccines Market Size by Country (2016-2021) 9.4.2 Latin America HIV Vaccines Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa HIV Vaccines Market Size (2016-2027) 10.2 Middle East & Africa HIV Vaccines Market Size by Type 10.2.1 Middle East & Africa HIV Vaccines Market Size by Type (2016-2021) 10.2.2 Middle East & Africa HIV Vaccines Market Size by Type (2022-2027) 10.2.3 Middle East & Africa HIV Vaccines Market Size by Type (2016-2027) 10.3 Middle East & Africa HIV Vaccines Market Size by Application 10.3.1 Middle East & Africa HIV Vaccines Market Size by Application (2016-2021) 10.3.2 Middle East & Africa HIV Vaccines Market Size by Application (2022-2027) 10.3.3 Middle East & Africa HIV Vaccines Market Size by Application (2016-2027) 10.4 Middle East & Africa HIV Vaccines Market Size by Country 10.4.1 Middle East & Africa HIV Vaccines Market Size by Country (2016-2021) 10.4.2 Middle East & Africa HIV Vaccines Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Argos Therapeutics 11.1.1 Argos Therapeutics Company Details 11.1.2 Argos Therapeutics Business Overview 11.1.3 Argos Therapeutics HIV Vaccines Introduction 11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2016-2021) 11.1.5 Argos Therapeutics Recent Development 11.2 Bionor Pharma 11.2.1 Bionor Pharma Company Details 11.2.2 Bionor Pharma Business Overview 11.2.3 Bionor Pharma HIV Vaccines Introduction 11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2016-2021) 11.2.5 Bionor Pharma Recent Development 11.3 Janssen Global Services 11.3.1 Janssen Global Services Company Details 11.3.2 Janssen Global Services Business Overview 11.3.3 Janssen Global Services HIV Vaccines Introduction 11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2016-2021) 11.3.5 Janssen Global Services Recent Development 11.4 Genecure 11.4.1 Genecure Company Details 11.4.2 Genecure Business Overview 11.4.3 Genecure HIV Vaccines Introduction 11.4.4 Genecure Revenue in HIV Vaccines Business (2016-2021) 11.4.5 Genecure Recent Development 11.5 Geovax, 11.5.1 Geovax, Company Details 11.5.2 Geovax, Business Overview 11.5.3 Geovax, HIV Vaccines Introduction 11.5.4 Geovax, Revenue in HIV Vaccines Business (2016-2021) 11.5.5 Geovax, Recent Development 11.6 Paxvax Corporation 11.6.1 Paxvax Corporation Company Details 11.6.2 Paxvax Corporation Business Overview 11.6.3 Paxvax Corporation HIV Vaccines Introduction 11.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2016-2021) 11.6.5 Paxvax Corporation Recent Development 11.7 Inovio Pharmaceuticals 11.7.1 Inovio Pharmaceuticals Company Details 11.7.2 Inovio Pharmaceuticals Business Overview 11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction 11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2016-2021) 11.7.5 Inovio Pharmaceuticals Recent Development 11.8 Glaxosmithkline 11.8.1 Glaxosmithkline Company Details 11.8.2 Glaxosmithkline Business Overview 11.8.3 Glaxosmithkline HIV Vaccines Introduction 11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2016-2021) 11.8.5 Glaxosmithkline Recent Development 11.9 Sanofi 11.9.1 Sanofi Company Details 11.9.2 Sanofi Business Overview 11.9.3 Sanofi HIV Vaccines Introduction 11.9.4 Sanofi Revenue in HIV Vaccines Business (2016-2021) 11.9.5 Sanofi Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Phase I Table 3. Key Players of Phase II Table 4. Key Players of Phase III Table 5. Global HIV Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global HIV Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global HIV Vaccines Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global HIV Vaccines Market Share by Regions (2016-2021) Table 9. Global HIV Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global HIV Vaccines Market Share by Regions (2022-2027) Table 11. HIV Vaccines Market Trends Table 12. HIV Vaccines Market Drivers Table 13. HIV Vaccines Market Challenges Table 14. HIV Vaccines Market Restraints Table 15. Global HIV Vaccines Revenue by Players (2016-2021) & (US$ Million) Table 16. Global HIV Vaccines Market Share by Players (2016-2021) Table 17. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2020) Table 18. Ranking of Global Top HIV Vaccines Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by HIV Vaccines Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players HIV Vaccines Product Solution and Service Table 22. Date of Enter into HIV Vaccines Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 25. Global HIV Vaccines Revenue Market Share by Type (2016-2021) Table 26. Global HIV Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global HIV Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global HIV Vaccines Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global HIV Vaccines Revenue Market Share by Application (2016-2021) Table 30. Global HIV Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global HIV Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 33. North America HIV Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 34. North America HIV Vaccines Market Size by Application (2016-2021) (US$ Million) Table 35. North America HIV Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 36. North America HIV Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 37. North America HIV Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 39. Europe HIV Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe HIV Vaccines Market Size by Application (2016-2021) (US$ Million) Table 41. Europe HIV Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe HIV Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe HIV Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific HIV Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific HIV Vaccines Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific HIV Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific HIV Vaccines Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific HIV Vaccines Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America HIV Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America HIV Vaccines Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America HIV Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America HIV Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America HIV Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa HIV Vaccines Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa HIV Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa HIV Vaccines Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa HIV Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa HIV Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa HIV Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 62. Argos Therapeutics Company Details Table 63. Argos Therapeutics Business Overview Table 64. Argos Therapeutics HIV Vaccines Product Table 65. Argos Therapeutics Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 66. Argos Therapeutics Recent Development Table 67. Bionor Pharma Company Details Table 68. Bionor Pharma Business Overview Table 69. Bionor Pharma HIV Vaccines Product Table 70. Bionor Pharma Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 71. Bionor Pharma Recent Development Table 72. Janssen Global Services Company Details Table 73. Janssen Global Services Business Overview Table 74. Janssen Global Services HIV Vaccines Product Table 75. Janssen Global Services Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 76. Janssen Global Services Recent Development Table 77. Genecure Company Details Table 78. Genecure Business Overview Table 79. Genecure HIV Vaccines Product Table 80. Genecure Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 81. Genecure Recent Development Table 82. Geovax, Company Details Table 83. Geovax, Business Overview Table 84. Geovax, HIV Vaccines Product Table 85. Geovax, Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 86. Geovax, Recent Development Table 87. Paxvax Corporation Company Details Table 88. Paxvax Corporation Business Overview Table 89. Paxvax Corporation HIV Vaccines Product Table 90. Paxvax Corporation Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 91. Paxvax Corporation Recent Development Table 92. Inovio Pharmaceuticals Company Details Table 93. Inovio Pharmaceuticals Business Overview Table 94. Inovio Pharmaceuticals HIV Vaccines Product Table 95. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 96. Inovio Pharmaceuticals Recent Development Table 97. Glaxosmithkline Company Details Table 98. Glaxosmithkline Business Overview Table 99. Glaxosmithkline Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 100. Glaxosmithkline Recent Development Table 101. Sanofi Company Details Table 102. Sanofi Business Overview Table 103. Sanofi HIV Vaccines Product Table 104. Sanofi Revenue in HIV Vaccines Business (2016-2021) & (US$ Million) Table 105. Sanofi Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global HIV Vaccines Market Share by Type: 2020 VS 2027 Figure 2. Phase I Features Figure 3. Phase II Features Figure 4. Phase III Features Figure 5. Global HIV Vaccines Market Share by Application: 2020 VS 2027 Figure 6. Research Institute Case Studies Figure 7. Other Case Studies Figure 8. HIV Vaccines Report Years Considered Figure 9. Global HIV Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global HIV Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global HIV Vaccines Market Share by Regions: 2020 VS 2027 Figure 12. Global HIV Vaccines Market Share by Regions (2022-2027) Figure 13. Global HIV Vaccines Market Share by Players in 2020 Figure 14. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2020 Figure 15. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2020 Figure 16. Global HIV Vaccines Revenue Market Share by Type (2016-2021) Figure 17. Global HIV Vaccines Revenue Market Share by Type (2022-2027) Figure 18. North America HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America HIV Vaccines Market Share by Type (2016-2027) Figure 20. North America HIV Vaccines Market Share by Application (2016-2027) Figure 21. North America HIV Vaccines Market Share by Country (2016-2027) Figure 22. United States HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe HIV Vaccines Market Share by Type (2016-2027) Figure 26. Europe HIV Vaccines Market Share by Application (2016-2027) Figure 27. Europe HIV Vaccines Market Share by Country (2016-2027) Figure 28. Germany HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific HIV Vaccines Market Share by Type (2016-2027) Figure 36. Asia-Pacific HIV Vaccines Market Share by Application (2016-2027) Figure 37. Asia-Pacific HIV Vaccines Market Share by Region (2016-2027) Figure 38. China HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America HIV Vaccines Market Share by Type (2016-2027) Figure 46. Latin America HIV Vaccines Market Share by Application (2016-2027) Figure 47. Latin America HIV Vaccines Market Share by Country (2016-2027) Figure 48. Mexico HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa HIV Vaccines Market Share by Type (2016-2027) Figure 52. Middle East & Africa HIV Vaccines Market Share by Application (2016-2027) Figure 53. Middle East & Africa HIV Vaccines Market Share by Country (2016-2027) Figure 54. Turkey HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE HIV Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Argos Therapeutics Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 58. Bionor Pharma Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 59. Janssen Global Services Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 60. Genecure Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 61. Geovax, Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 62. Paxvax Corporation Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 63. Inovio Pharmaceuticals Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 64. Glaxosmithkline Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 65. Sanofi Revenue Growth Rate in HIV Vaccines Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Argos Therapeutics Bionor Pharma Janssen Global Services Genecure Geovax, Paxvax Corporation Inovio Pharmaceuticals Glaxosmithkline Sanofi